|
Calibrating COVID-19: The Interplay of Disease Modifying Therapy and Vaccination in Patients with Multiple Sclerosis |
- 0.50 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Conversations in Neurology: New Agents and Strategies for Migraine and Related Headache Disorders Edition (Credit Expired) |
|
Enduring |
|
$0.00 |
|
Critical & Contested – A High-Yield Educational Series Addressing Difficult and Valuable Topics in Rare Neurologic Disorders: Neuromyelitis... |
- 0.50 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Devil in the Details: An Expert Guide to Modern Multiple Sclerosis Practices |
- 1.50 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Finding Something in Nothing: Patient-Centered Approaches to Resolve Emotional Blunting in Major Depressive Disorder |
- 0.75 AMA PRA Category 1 Credit™
- 0.75 Attendance
|
Enduring |
|
$0.00 |
|
How Do I…? An Integrated CME Activity Designed to Assess and Compare the Clinical Decisions of Multiple Sclerosis Specialists and General... |
|
Enduring |
|
$0.00 |
|
Multiple Sclerosis Management: Shedding Light on the Patient Perspective |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC
|
Enduring |
|
$0.00 |
|
Networks in Neurology: Insights From a Collaborative CME Experience With Practicing Clinicians Regarding New Agents and Strategies for Multiple... |
- 0.75 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
On Target with “OFF” Therapies: An Exploration of New Agents and Strategies for Parkinson’s Disease |
- 1.00 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) --... |
|
Enduring |
|
$0.00 |
|
The Path of Least Resistance: New Agents and Emerging Strategies for Managing Childhood-Onset and Refractory Epilepsies |
- 1.00 AMA PRA Category 1 Credit™
|
Enduring |
|
$0.00 |
|
Wake up: Modern Strategies to Recognize and Combat Sleepiness in Narcolepsy and Idiopathic Hypersomnia - An Adaptation of a Virtual Grand Rounds... |
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Attendance
|
Enduring |
|
$0.00 |
|
What Can Biomarkers Tell Us? Modern Tools to Assist Navigating Prognosis, Monitoring, and Therapeutic Decision-Making in the Long-Term Management of... |
|
Live |
06/01/2022 - 4:00pm EDT |
$0.00 |
|
Why Now? The New Paradigm and Rising Role of Nuclear Medicine in Alzheimer’s Disease |
- 1.00 AMA PRA Category 1 Credit™
|
Live |
06/14/2022 - 2:45pm EDT |
$0.00 |
Facebook
Twitter
LinkedIn
Forward